These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 7643095

  • 1. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase.
    Chiarugi A, Carpenedo R, Molina MT, Mattoli L, Pellicciari R, Moroni F.
    J Neurochem; 1995 Sep; 65(3):1176-83. PubMed ID: 7643095
    [Abstract] [Full Text] [Related]

  • 2. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
    Carpenedo R, Chiarugi A, Russi P, Lombardi G, Carlà V, Pellicciari R, Mattoli L, Moroni F.
    Neuroscience; 1994 Jul; 61(2):237-43. PubMed ID: 7969905
    [Abstract] [Full Text] [Related]

  • 3. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
    Chiarugi A, Carpenedo R, Moroni F.
    J Neurochem; 1996 Aug; 67(2):692-8. PubMed ID: 8764597
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.
    Pellicciari R, Natalini B, Costantino G, Mahmoud MR, Mattoli L, Sadeghpour BM, Moroni F, Chiarugi A, Carpenedo R.
    J Med Chem; 1994 Mar 04; 37(5):647-55. PubMed ID: 8126705
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of quinolinic acid synthesis by mitochondria and o-methoxybenzoylalanine.
    Chiarugi A, Moroni F.
    Adv Exp Med Biol; 1999 Mar 04; 467():233-9. PubMed ID: 10721061
    [Abstract] [Full Text] [Related]

  • 13. Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis.
    Chiarugi A, Moroni F.
    J Neurochem; 1999 Mar 04; 72(3):1125-32. PubMed ID: 10037484
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
    Badawy AA.
    Med Hypotheses; 2018 Sep 04; 118():129-138. PubMed ID: 30037600
    [Abstract] [Full Text] [Related]

  • 18. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
    Ceresoli-Borroni G, Guidetti P, Amori L, Pellicciari R, Schwarcz R.
    J Neurosci Res; 2007 Mar 04; 85(4):845-54. PubMed ID: 17279543
    [Abstract] [Full Text] [Related]

  • 19. Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity.
    Connick JH, Heywood GC, Sills GJ, Thompson GG, Brodie MJ, Stone TW.
    Gen Pharmacol; 1992 Mar 04; 23(2):235-9. PubMed ID: 1639238
    [Abstract] [Full Text] [Related]

  • 20. 28833, a selective kynurenine 3-hydroxylase inhibitor. Effects on the kynurenine pathway metabolites in the gerbil.
    Cini M, Bormetti R, Marconi M, Molinari A, Veneroni O, Varasi M, Schwarcz R, Speciale C.
    Adv Exp Med Biol; 1996 Mar 04; 398():535-8. PubMed ID: 8906318
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.